Your browser doesn't support javascript.
loading
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus.
Mpilla, Gabriel B; Uddin, Md Hafiz; Al-Hallak, Mohammed N; Aboukameel, Amro; Li, Yiwei; Kim, Steve H; Beydoun, Rafic; Dyson, Gregory; Baloglu, Erkan; Senapedis, William T; Landesman, Yosef; Wagner, Kay-Uwe; Viola, Nerissa T; El-Rayes, Bassel F; Philip, Philip A; Mohammad, Ramzi M; Azmi, Asfar S.
Afiliación
  • Mpilla GB; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Uddin MH; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Al-Hallak MN; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Aboukameel A; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Li Y; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Kim SH; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Beydoun R; Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Dyson G; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Baloglu E; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Senapedis WT; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Landesman Y; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Wagner KU; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Viola NT; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • El-Rayes BF; Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Philip PA; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Mohammad RM; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan.
  • Azmi AS; Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan. azmia@karmanos.org.
Mol Cancer Ther ; 20(10): 1836-1845, 2021 10.
Article en En | MEDLINE | ID: mdl-34253597
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Acrilamidas / Regulación Neoplásica de la Expresión Génica / Citocinas / Tumores Neuroendocrinos / Nicotinamida Fosforribosiltransferasa / Quinasas p21 Activadas / Everolimus / Aminopiridinas Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Acrilamidas / Regulación Neoplásica de la Expresión Génica / Citocinas / Tumores Neuroendocrinos / Nicotinamida Fosforribosiltransferasa / Quinasas p21 Activadas / Everolimus / Aminopiridinas Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article